Next Article in Journal / Special Issue
The Tetraspanin CD151 in Papillomavirus Infection
Previous Article in Journal
Anti-Tumor Effects of an Oncolytic Adenovirus Expressing Hemagglutinin-Neuraminidase of Newcastle Disease Virus in Vitro and in Vivo
Previous Article in Special Issue
CD81 and Hepatitis C Virus (HCV) Infection
Review

CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies

1
Inserm, U1110, 67000 Strasbourg, France
2
University of Strasbourg, 67000 Strasbourg, France
3
Pôle Hépato-digestif, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Viruses 2014, 6(2), 875-892; https://doi.org/10.3390/v6020875
Received: 3 December 2013 / Revised: 12 February 2014 / Accepted: 13 February 2014 / Published: 18 February 2014
(This article belongs to the Special Issue Viruses and Tetraspanins)
Tetraspanins are integral transmembrane proteins organized in microdomains displaying specific and direct interactions with other tetraspanins and molecular partners. Among them, CD81 has been implicated in a variety of physiological and pathological processes. CD81 also plays a crucial role in pathogen entry into host cells, including hepatitis C virus (HCV) entry into hepatocytes. HCV is a major cause of liver cirrhosis and hepatocellular carcinoma. HCV entry into hepatocytes is a complex process that requires the coordinated interaction of viral and host factors for the initiation of infection, including CD81, scavenger receptor BI, claudin-1, occludin, membrane-bound host cell kinases, Niemann-Pick C1 Like 1, Harvey rat sarcoma viral oncogene homolog (HRas), CD63 and transferrin receptor 1. Furthermore, recent data in HCV model systems have demonstrated that targeting critical components of tetraspanins and associated cell membrane proteins open new avenues to prevent and treat viral infection. View Full-Text
Keywords: antivirals; claudin-1; kinases; liver; transplantation antivirals; claudin-1; kinases; liver; transplantation
Show Figures

Graphical abstract

MDPI and ACS Style

Zona, L.; Tawar, R.G.; Zeisel, M.B.; Xiao, F.; Schuster, C.; Lupberger, J.; Baumert, T.F. CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies. Viruses 2014, 6, 875-892. https://doi.org/10.3390/v6020875

AMA Style

Zona L, Tawar RG, Zeisel MB, Xiao F, Schuster C, Lupberger J, Baumert TF. CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies. Viruses. 2014; 6(2):875-892. https://doi.org/10.3390/v6020875

Chicago/Turabian Style

Zona, Laetitia, Rajiv G. Tawar, Mirjam B. Zeisel, Fei Xiao, Catherine Schuster, Joachim Lupberger, and Thomas F. Baumert 2014. "CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies" Viruses 6, no. 2: 875-892. https://doi.org/10.3390/v6020875

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop